About BBIEX
The Bridge Builder International Equity Fund is an open-end mutual fund focused on providing broad global equity exposure outside the United States, specifically within the foreign large blend category. The fund’s primary objective is to invest at least 80% of its net assets in equities of companies that have a significant presence or derive at least half their revenue from operations outside the U.S. Its portfolio spans multiple regions and sectors, with prominent holdings in healthcare, financial services, technology, energy, and utilities. Top holdings include notable multinational corporations such as Novo Nordisk, Sanofi, Sony Group, and Shell, reflecting a diversified approach within developed and emerging markets. Launched in 2015, the fund emphasizes cost efficiency, maintaining a low expense ratio compared to peers, and is managed by a team recognized for disciplined processes and risk management. With a substantial asset base and robust liquidity, the fund plays a significant role in the international allocation of diversified investment portfolios, aiming to capture opportunities in foreign markets while balancing risk across industries and geographies.
Fund Family Bridge Builder
Category Foreign Large Blend
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol BBIEX
Index MSCI EAFE NR USD
BBIEX had a total return of 9.33% in the past year, including dividends. Since the fund's
inception, the average annual return has been 7.82%.
